ENTPD1 and glioblastoma: Glioblastoma with combined elevation of CD73 and CD39 (i.e., CD73hi/CD39hi tumors) were enriched for immune populations, while those with low levels of both enzymes (CD73loCD39lo) were depleted for nearly all immune cell populations.